MRVI

7.85

1.03% 0.08

Handel nachbörslich: 7.85

Maravai Lifesciences Holdings Inc (MRVI)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt MRVI? Forum Prognose

Schlusskurs vom Vortag:

$7.77

Offen:

$7.62

24-Stunden-Volumen:

1.76M

Relative Volume:

0.94

Marktkapitalisierung:

$1.11B

Einnahmen:

$288.95M

Nettoeinkommen (Verlust:

$-119.03M

KGV:

13.78

EPS:

0.5695

Netto-Cashflow:

$60.67M

1W Leistung:

+10.41%

1M Leistung:

-0.51%

6M Leistung:

-12.49%

1J Leistung:

+13.77%

1-Tages-Spanne:

$7.61

$7.93

1-Wochen-Bereich:

$7.08

$7.93

52-Wochen-Spanne:

$4.52

$11.55

Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile

Firmenname

Maravai Lifesciences Holdings Inc

Sektor

Healthcare (1182)

Branche

Biotechnology (671)

Telefon

(858) 546-0004

Adresse

10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO

Mitarbeiter

580

Twitter

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

MRVI's Discussions on Twitter

Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-08-08	Herabstufung	KeyBanc Capital Markets	Overweight → Sector Weight
2023-05-23	Herabstufung	Credit Suisse	Outperform → Neutral
2023-05-09	Herabstufung	Goldman	Buy → Neutral
2023-01-05	Herabstufung	UBS	Buy → Neutral
2022-12-14	Eingeleitet	Deutsche Bank	Buy
2022-12-07	Eingeleitet	RBC Capital Mkts	Outperform
2022-11-03	Herabstufung	BofA Securities	Buy → Neutral
2022-08-25	Eingeleitet	Credit Suisse	Outperform
2021-08-05	Fortgesetzt	Credit Suisse	Outperform
2020-12-16	Eingeleitet	KeyBanc Capital Markets	Overweight
2020-12-15	Eingeleitet	BofA Securities	Buy
2020-12-15	Eingeleitet	Credit Suisse	Outperform
2020-12-15	Eingeleitet	Goldman	Buy
2020-12-15	Eingeleitet	Jefferies	Buy
2020-12-15	Eingeleitet	Robert W. Baird	Outperform
2020-12-15	Eingeleitet	Stifel	Buy
2020-12-15	Eingeleitet	William Blair	Outperform
2020-12-14	Eingeleitet	UBS	Buy

Alle ansehen

Maravai Lifesciences Holdings Inc Aktie (MRVI) Neueste Nachrichten

10:46 AM

(MRVI) Investment Analysis and Advice - Stock Traders Daily

10:46 AM

Nov 04, 2024

MRVI Stock Surges Amid Biotechnology Sector Fluctuations - GuruFocus.com

Nov 04, 2024

Nov 03, 2024

Cannon Global Investment Management LLC Makes New $590,000 Investment in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat

Nov 03, 2024

Oct 31, 2024

Roubaix Capital LLC Trims Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat

Oct 31, 2024

Maravai LifeSciences Sees Unusually Large Options Volume (NASDAQ:MRVI) - MarketBeat

Oct 31, 2024

Maravai LifeSciences (MRVI) to Release Earnings on Thursday - MarketBeat

Oct 31, 2024

Oct 30, 2024

Maravai LifeSciences (NASDAQ:MRVI) Trading Up 7%Still a Buy? - MarketBeat

Oct 30, 2024

Oct 29, 2024

Millennium Management LLC Adjusts Stake in Maravai LifeSciences Holdings Inc - GuruFocus.com

Oct 29, 2024

Oct 28, 2024

Where Do Analysts See Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) Heading? - Stocks Register

Oct 28, 2024

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Receives $10.67 Average PT from Brokerages - MarketBeat

Oct 28, 2024

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Rating of “Moderate Buy” by Analysts - Defense World

Oct 28, 2024

Oct 25, 2024

(MRVI) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Oct 25, 2024

Oct 22, 2024

Maravai LifeSciences (NASDAQ:MRVI) Shares Down 4.6%Here's Why - MarketBeat

Oct 22, 2024

Oct 18, 2024

43,372 Shares in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Bought by The Manufacturers Life Insurance Company - Defense World

Oct 18, 2024

Oct 17, 2024

Stock Traders Buy Large Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI) - MarketBeat

Oct 17, 2024

Oct 15, 2024

Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024 - GlobeNewswire

Oct 15, 2024